Orthofix Medical Inc. (NASDAQ:OFIX) Major Shareholder Acquires $13,887.50 in Stock

Orthofix Medical Inc. (NASDAQ:OFIX - Get Free Report) major shareholder Engine Capital Management, Lp bought 1,250 shares of Orthofix Medical stock in a transaction dated Wednesday, July 2nd. The stock was acquired at an average price of $11.11 per share, with a total value of $13,887.50. Following the purchase, the insider directly owned 3,546,057 shares of the company's stock, valued at approximately $39,396,693.27. This represents a 0.04% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Large shareholders that own at least 10% of a company's stock are required to disclose their transactions with the SEC.

Engine Capital Management, Lp also recently made the following trade(s):

• On Wednesday, May 7th, Engine Capital Management, Lp purchased 100,000 shares of Orthofix Medical stock. The stock was bought at an average price of $12.31 per share, with a total value of $1,231,000.00.

Orthofix Medical Price Performance

Orthofix Medical stock traded up $0.42 during midday trading on Tuesday, hitting $11.14. 104,046 shares of the company's stock were exchanged, compared to its average volume of 288,770. Orthofix Medical Inc. has a 52-week low of $10.24 and a 52-week high of $20.73. The stock has a 50-day moving average price of $11.54 and a two-hundred day moving average price of $14.92. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.50 and a current ratio of 2.71. The company has a market cap of $436.27 million, a P/E ratio of -3.03 and a beta of 0.80.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of OFIX. Juniper Investment Company LLC grew its position in Orthofix Medical by 123.5% in the fourth quarter. Juniper Investment Company LLC now owns 1,937,249 shares of the medical device company's stock worth $33,824,000 after acquiring an additional 1,070,656 shares in the last quarter. Philosophy Capital Management LLC purchased a new position in shares of Orthofix Medical in the 1st quarter worth about $6,047,000. Engine Capital Management LP boosted its holdings in shares of Orthofix Medical by 8.4% in the 1st quarter. Engine Capital Management LP now owns 3,741,390 shares of the medical device company's stock worth $61,022,000 after purchasing an additional 290,646 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Orthofix Medical by 244.1% in the 4th quarter. JPMorgan Chase & Co. now owns 290,351 shares of the medical device company's stock worth $5,070,000 after purchasing an additional 205,972 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Orthofix Medical by 31.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 659,475 shares of the medical device company's stock worth $11,515,000 after purchasing an additional 159,177 shares in the last quarter. 89.76% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have recently weighed in on OFIX. Wall Street Zen cut Orthofix Medical from a "hold" rating to a "sell" rating in a research report on Friday, June 27th. Barrington Research raised Orthofix Medical to a "strong-buy" rating and set a $16.00 target price for the company in a report on Monday, June 23rd. Finally, JMP Securities reaffirmed a "market perform" rating on shares of Orthofix Medical in a report on Friday, June 6th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $21.50.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.